Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:ARCK

Arbor Rapha Capital Bioholdings Corp. I (ARCK) Stock Price, News & Analysis

Arbor Rapha Capital Bioholdings Corp. I logo

About Arbor Rapha Capital Bioholdings Corp. I Stock (NASDAQ:ARCK)

Advanced Chart

Key Stats

Today's Range
$11.90
$11.90
50-Day Range
$10.42
$15.41
52-Week Range
$9.93
$15.59
Volume
N/A
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Arbor Rapha Capital Bioholdings Corp. I does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar Business Combination with one or more businesses. It intends to identify acquisition opportunities in the biopharmaceutical sector. The company was incorporated in 2021 and is based in Uniondale, New York.

Receive ARCK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arbor Rapha Capital Bioholdings Corp. I and its competitors with MarketBeat's FREE daily newsletter.

ARCK Stock News Headlines

DRGV Dragon Capital Group, Corp.
ECN Capital Corp. (ECNCF)
Market down? Do this now.
During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now, history is repeating itself. Here's the truth: Tariffs create uncertainty. Uncertainty drives investors to gold. And gold prices rise as a result. It's a cycle that's already beginning again—and it's your chance to profit. Why wait? Greed isn't always a bad thing—especially when it comes to protecting and growing your wealth. The smartest investors are already moving their money into gold, and you should too.
SuRo Capital Corp.
Ready Capital Corp.
Oxford Lane Capital Corp. (OXLC)
Deal Pro Capital Corporation (DPCC-P.V)
Quad 7 Capital
See More Headlines

ARCK Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Arbor Rapha Capital Bioholdings Corp. I investors own include Criteo (CRTO), AzurRx BioPharma (AZRX), Alnylam Pharmaceuticals (ALNY), Argos Therapeutics (ARGSQ), Editas Medicine (EDIT), Abrdn Asia-Pacific Income Fund (FAX) and Weidai (WEI).

Company Calendar

Today
2/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Industry
Holding & other investment offices
Sub-Industry
N/A
Current Symbol
NASDAQ:ARCK
Fax
N/A
Employees
2,021
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
10 Best Stocks to Own in 2025 Cover

Enter your email address and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:ARCK) was last updated on 2/23/2025 by MarketBeat.com Staff
From Our Partners